Q/C Technologies, Inc.
QCLS- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001321834
No open-market purchases or sales by Q/C Technologies, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.87M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Q/C Technologies, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- 0 vs. Q4 2025
- Shares held
- 627.6K
- −72.1K (−10.3%) vs. Q4 2025
- Total value
- $2.16M
- −$626.8K (−22.5%) vs. Q4 2025
- New holders
- 7
- 5 more added
- Sold out
- 7
- 1 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QCLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $2.87M |
| Q1 2026 | 18 | $2.16M |
| Q4 2025 | 19 | $3.00M |
| Q3 2025 | 12 | $69.8K |
| Q2 2025 | 33 | $65.3K |
| Q1 2025 | 24 | $69.0K |
| Q4 2024 | 25 | $145.8K |
| Q3 2024 | 20 | $60.3K |
| Q2 2024 | 23 | $114.6K |
| Q1 2024 | 20 | $1.38M |
| Q4 2023 | 50 | $1.64M |
| Q3 2023 | 51 | $2.52M |
| Q2 2023 | 48 | $6.51M |
| Q1 2023 | 50 | $6.98M |
| Q4 2022 | 43 | $4.49M |
| Q3 2022 | 43 | $9.94M |
| Q2 2022 | 39 | $10.3M |
| Q1 2022 | 35 | $22.4M |
| Q4 2021 | 41 | $27.1M |
| Q3 2021 | 28 | $41.8M |
| Q2 2021 | 23 | $30.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Q/C Technologies, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 6 | $0 | 0.00% | +2+50.0% | Added |
| Bryn Mawr Trust Co | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 2 | $7 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 19 | $66 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 300 | $1.03K | 0.00% | −900−75.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,593 | $5.50K | 0.00% | +1,358+577.9% | Added |
| Sunbelt Securities, Inc. | 1,750 | $6.04K | 0.00% | +1,750 | New |
| Pin Oak Investment Advisors Inc | 3,500 | $12.0K | 0.01% | +3,500 | New |
| State Street Corp | 12,905 | $44.5K | 0.00% | +12,905 | New |
| Vanguard Fiduciary Trust Co | 15,555 | $53.7K | 0.00% | +15,555 | New |
| Dimensional Fund Advisors LP | 19,058 | $65.8K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 22,404 | $77.0K | 0.00% | +22,404 | New |
| Vanguard Capital Management LLC | 37,511 | $129.4K | 0.00% | +37,511 | New |
| Geode Capital Management, LLC | 47,390 | $163.5K | 0.00% | +18,138+62.0% | Added |
| ADAR1 Capital Management, LLC | 50,000 | $172.5K | 0.01% | +50,000 | New |
| UBS Group AG | 77,989 | $269.1K | 0.00% | +60,564+347.6% | Added |
| Jane Street Group, LLC | 126,188 | $435.3K | 0.00% | +85,702+211.7% | Added |
| Quinn Opportunity Partners LLC | 211,390 | $729.3K | 0.04% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −333,826−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −35,380−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,333−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |